Xiang-Yu Meng

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Alcohol Consumption

Multiple Myeloma

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Disease markers

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yuying Hou, Xiang-Yu Meng, Xiong-Hui Zhou
Systematically Evaluating Cell-Free DNA Fragmentation Patterns for Cancer Diagnosis and Enhanced Cancer Detection via Integrating Multiple Fragmentation Patterns. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Yuying Hou, Xiang-Yu Meng, Xiong-Hui Zhou
Systematically Evaluating Cell-Free DNA Fragmentation Patterns for Cancer Diagnosis and Enhanced Cancer Detection via Integrating Multiple Fragmentation Patterns. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (30) (2024)
Yuying Hou, Xiang-Yu Meng, Xiong-Hui Zhou
Systematically Evaluating Cell-Free DNA Fragmentation Patterns for Cancer Diagnosis and Enhanced Cancer Detection via Integrating Multiple Fragmentation Patterns. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (30) (2024)
Yi-Tong Liu, Xiang-Yu Meng
The underexplored role of APOBEC3 enzymes in autoimmune diseases. Rheumatology (Oxford, England) (2023)
Xiang-Yu Meng
"Paradoxical neoantigenic mutations": not simply a driver vs passenger dualism. British journal of cancer (2023)
Xiang-Yu Meng
Comments on "Methylation scores for smoking, alcohol consumption and body mass index and risk of seven types of cancer". International journal of cancer (2023)
Xiang-Yu Meng, Qiu-Ji Wu
Tumor mutation burden as a marker for molecularly matched therapy: more evidence needed. Epigenomics (2023)
Xiang-Yu Meng
NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors. Journal for immunotherapy of cancer 11 (6) (2023)
Shuo Li, Xiang-Yu Meng, Souraka Tapara Dramani Maman, Yong-Nong Xiao, Sheng Li
Lenalidomide and Low Dose Dexamethasone Plus Elotuzumab or Carfilzomib for Relapsed or Refractory Multiple Myeloma: A Comparison of Progression-Free Survival with Reconstructed Individual Participant Data. BioMed research international 2018 (2018)
Xiang-Yu Meng, Ming-Jun Shi, Jia-Feng Chen, Yi Liao, Bang-Wang Hu, Ahmed Hireche
Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence. Disease markers 2017 (2017)
Xiao-Wei Jia, Ya-Di Yuan, Zhong-Xiong Yao, Chang-Jing Wu, Xiang Chen, Xue-Hong Chen, Ying-Mei Lin, Xiang-Yu Meng, Xian-Tao Zeng, Jun Shao
Association between IL-4 and IL-4R Polymorphisms and Periodontitis: A Meta-Analysis. Disease markers 2017 (2017)